Skip to Main Content

Paper Details

ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS.
Endocr Pract
4
2019
(Chr) 18, 37 lesions, Chr, Chr 13, Chr 18, Chr 5, DNA, GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS, GEP, GEP-, GEP-NET, MEN-1, NET, PNET, SINET, Tumor deoxyribonucleic acid, actionable genes, chromosome, deoxyribonucleic acid, everolimus, gastro-enteropancreatic (GEP) neuroendocrine tumors, genes, germline DNA, mTOR, mTOR pathway-associated genes, mammalian target of rapamycin, multiple endocrine neoplasia syndrome type 1, multiple lesions, neuroendocrine tumor, oncogenes, pancreatic neuroendocrine tumors, patients, rapamycin, small-intestine neuroendocrine tumor, sporadic NET, tumor, tumor suppressor genes, tumors

Datasets

Dataset
Description
Source Link
OncoVarDriver mutations, genes and pathways in cancerLink
OncoVarDriver mutations, genes and pathways in cancerLink
OncoVarDriver mutations, genes and pathways in cancerLink
Release 1.2